Physician profile
David Templin
NPI 1023100922
$5,721.70
in general payments reported to CMS, 2019-2025
21 companies · $2,055 in 2025
The $2,055 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $1,184 · 2021: $391 · 2022: $584 · 2023: $837 · 2024: $374 · 2025: $2,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,626 · Travel and Lodging: $1,572 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.38 |
| Travel and Lodging | $1,572.40 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,562.78 | 2025 | Oxford, Oxford Partial Knee |
| Medinc of Texas | $1,151.00 | 2020 | |
| Stryker Corporation | $981.24 | 2019-2025 | Mako, Pangea, Biolox |
| Amgen INC. | $432.70 | 2023-2024 | Tavneos, Otezla |
| Avanos Medical | $218.13 | 2021 | |
| Abbott Laboratories | $198.87 | 2022-2023 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $167.54 | 2019-2023 | Iovera, Zilretta, Exparel |
| Organogenesis INC. | $146.05 | 2023 | Puraply |
| Si-Bone, INC. | $141.20 | 2025 | |
| Arthrex, INC. | $132.90 | 2025 | |
| Medtronic, INC. | $130.58 | 2024 | Kyphon Express II Kyphopak Tray |
| Alexion Pharmaceuticals, INC. | $116.24 | 2021 | |
| Spr Therapeutics, INC | $77.50 | 2024 | Sprint Pns System |
| Surmodics, INC. | $73.29 | 2022 | |
| Bioventus LLC | $46.88 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $33.96 | 2020-2021 | |
| Anika Therapeutics, INC. | $32.06 | 2023 | Revomotion |
| Vericel Corporation | $24.47 | 2020-2022 | |
| Smith+Nephew, INC. | $19.62 | 2022 | |
| Globus Medical, INC. | $18.56 | 2019 | |
| Depuy Synthes Sales INC. | $16.13 | 2024 | Truespan Orthocord |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Templin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.